semaglutide and antipsychotics Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September Among patients with #Schizophrenia treated
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5







![🎉 Week 1 on Ozempic [My First Dose & Why I’m Starting This Journey]](https://i.ytimg.com/vi/Ih4NjUV6Ah8/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLDn7y36CUGeOmRaLDSLRaBQB5ohrA)

















